Ainos Revenue and Competitors
Estimated Revenue & Valuation
- Ainos's estimated annual revenue is currently $1.4M per year.
- Ainos's estimated revenue per employee is $155,000
Employee Data
- Ainos has 9 Employees.
- Ainos grew their employee count by 29% last year.
Ainos's People
| Name | Title | Email/Phone |
|---|---|---|
1 | EVP Operations | Reveal Email/Phone |
Ainos Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Ainos?
Ainos = AI + Nose Ainos, Inc. (Nasdaq: AIMD) is a diversified healthcare company focused on the development of novel point-of-care testing (POCT), low-dose VELDONA interferon therapeutics, and synthetic RNA-driven preventative medicine. The company’s products include VELDONA clinical-stage human therapeutics, VELDONA Pet Cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. twitter: https://twitter.com/AinosInc #AinosInc
keywords:N/A
N/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.7M | 9 | N/A | N/A |
#2 | $0.7M | 9 | N/A | N/A |
#3 | $0.7M | 9 | N/A | N/A |
#4 | $0.7M | 9 | N/A | N/A |
#5 | $0.7M | 9 | N/A | N/A |